Addus HomeCare (ADUS) Stock Forecast, Price Target & Predictions
ADUS Stock Forecast
Addus HomeCare stock forecast is as follows: an average price target of $123.00 (represents a -5.48% downside from ADUS’s last price of $130.13) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
ADUS Price Target
ADUS Analyst Ratings
Addus HomeCare Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 08, 2024 | Frank Morgan | RBC Capital | $141.00 | $122.22 | 15.37% | 8.35% |
Aug 07, 2024 | Michael Wiederhorn | Oppenheimer | $140.00 | $122.22 | 14.55% | 7.58% |
Jun 07, 2024 | Michael Wiederhorn | Oppenheimer | $130.00 | $116.07 | 12.00% | -0.10% |
May 31, 2024 | Scott Fidel | Stephens | $128.00 | $111.73 | 14.56% | -1.64% |
May 28, 2024 | Frank Morgan | RBC Capital | $129.00 | $111.61 | 15.58% | -0.87% |
Apr 23, 2024 | Andrew Mok | Barclays | $83.00 | $93.14 | -10.89% | -36.22% |
Apr 01, 2024 | Scott Fidel | Stephens | $115.00 | $103.34 | 11.28% | -11.63% |
Jun 29, 2022 | Scott Fidel | Stephens | $101.00 | $85.14 | 18.63% | -22.39% |
May 04, 2022 | - | RBC Capital | $111.00 | $82.34 | 34.81% | -14.70% |
Addus HomeCare Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 2 | 7 |
Avg Price Target | - | $140.50 | $123.71 |
Last Closing Price | $130.13 | $130.13 | $130.13 |
Upside/Downside | -100.00% | 7.97% | -4.93% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 03, 2024 | Stephens | Buy | Buy | Hold |
Sep 03, 2024 | RBC Capital | Underperform | Underperform | Hold |
Aug 08, 2024 | Cowen & Co. | Buy | Buy | Hold |
Aug 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
Aug 07, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Aug 07, 2024 | Stephens | Overweight | Overweight | Hold |
Aug 06, 2024 | Oppenheimer | Underperform | Underperform | Hold |
Aug 06, 2024 | Stephens | Buy | Buy | Hold |
Jun 28, 2024 | Macquarie | - | Outperform | Initialise |
Jun 18, 2024 | Oppenheimer | Underperform | Underperform | Hold |
Addus HomeCare Financial Forecast
Addus HomeCare Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $276.35M | $270.72M | $259.98M | $251.60M | $247.05M | $240.50M | - | $226.63M | $224.64M | $216.66M | $217.89M | $205.30M | $196.00M | $193.99M | $184.58M | $190.22M | $190.04M | $169.80M |
Avg Forecast | $390.26M | $391.38M | $387.65M | $375.48M | $350.37M | $349.09M | $339.28M | $331.02M | $297.29M | $289.62M | $284.90M | $279.49M | $274.47M | $267.15M | $256.31M | $250.05M | $246.14M | $242.20M | $238.48M | $227.40M | $226.21M | $226.34M | $216.79M | $209.78M | $197.71M | $189.16M | $172.12M | $177.94M | $182.91M | $159.89M |
High Forecast | $392.74M | $393.87M | $390.11M | $377.87M | $352.60M | $351.31M | $341.44M | $333.12M | $299.18M | $291.75M | $286.71M | $281.26M | $276.73M | $268.85M | $257.94M | $251.64M | $247.71M | $243.74M | $238.48M | $230.14M | $228.93M | $229.07M | $219.40M | $212.30M | $200.09M | $191.43M | $174.19M | $180.08M | $185.11M | $161.81M |
Low Forecast | $386.68M | $387.79M | $384.09M | $372.03M | $347.15M | $345.88M | $336.17M | $327.98M | $294.56M | $287.30M | $282.28M | $276.92M | $271.94M | $264.70M | $253.96M | $247.76M | $243.88M | $239.98M | $238.48M | $224.43M | $223.26M | $223.39M | $213.96M | $207.04M | $195.13M | $186.69M | $169.88M | $175.62M | $180.52M | $157.80M |
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 3 | 4 | 5 | 6 | 4 | 6 | 4 | 6 | 4 | 5 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.01% | 1.01% | 1.01% | 1.00% | 0.99% | - | 1.00% | 0.99% | 0.96% | 1.01% | 0.98% | 0.99% | 1.03% | 1.07% | 1.07% | 1.04% | 1.06% |
Addus HomeCare EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 3 | 4 | 5 | 6 | 4 | 6 | 4 | 6 | 4 | 5 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $33.02M | $27.04M | $24.92M | $22.05M | $24.30M | $20.96M | - | $17.09M | $23.44M | $20.80M | $20.67M | $15.79M | $14.94M | $15.65M | $12.70M | $13.88M | $17.15M | $10.25M |
Avg Forecast | $33.65M | $33.74M | $33.42M | $32.37M | $30.21M | $30.10M | $29.25M | $28.54M | $25.63M | $24.97M | $24.56M | $20.41M | $23.66M | $23.03M | $22.10M | $18.55M | $21.22M | $23.44M | $20.56M | $16.87M | $22.16M | $21.31M | $21.18M | $15.79M | $13.55M | $13.01M | $7.13M | $10.80M | $15.77M | $9.54M |
High Forecast | $33.86M | $33.96M | $33.64M | $32.58M | $30.40M | $30.29M | $29.44M | $28.72M | $25.80M | $25.15M | $24.72M | $24.49M | $23.86M | $23.18M | $22.24M | $22.26M | $21.36M | $28.13M | $20.56M | $20.24M | $26.59M | $25.57M | $25.42M | $18.95M | $16.26M | $15.61M | $8.55M | $12.96M | $15.96M | $11.45M |
Low Forecast | $33.34M | $33.43M | $33.12M | $32.08M | $29.93M | $29.82M | $28.98M | $28.28M | $25.40M | $24.77M | $24.34M | $16.33M | $23.45M | $22.82M | $21.90M | $14.84M | $21.03M | $18.75M | $20.56M | $13.49M | $17.73M | $17.05M | $16.95M | $12.63M | $10.84M | $10.40M | $5.70M | $8.64M | $15.56M | $7.63M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.40% | 1.17% | 1.13% | 1.19% | 1.15% | 0.89% | - | 1.01% | 1.06% | 0.98% | 0.98% | 1.00% | 1.10% | 1.20% | 1.78% | 1.29% | 1.09% | 1.07% |
Addus HomeCare Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 3 | 4 | 5 | 6 | 4 | 6 | 4 | 6 | 4 | 5 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $19.58M | $15.41M | $14.85M | $12.68M | $14.76M | $11.54M | - | $8.47M | $13.06M | $11.58M | $11.60M | $8.89M | $8.45M | $9.12M | $6.91M | $8.66M | $9.99M | $4.87M |
Avg Forecast | $28.41M | $27.18M | $26.70M | $23.97M | $26.69M | $24.70M | $24.24M | $22.51M | $22.47M | $21.44M | $20.03M | $10.11M | $19.34M | $17.87M | $16.66M | $9.19M | $15.72M | $13.05M | $14.78M | $8.36M | $12.35M | $11.86M | $11.89M | $8.89M | $7.66M | $7.58M | $3.88M | $6.73M | $10.74M | $4.53M |
High Forecast | $28.65M | $27.40M | $26.92M | $24.17M | $26.91M | $24.91M | $24.44M | $22.70M | $22.65M | $22.10M | $20.20M | $12.14M | $19.67M | $18.01M | $16.80M | $11.03M | $15.85M | $15.65M | $14.78M | $10.03M | $14.82M | $14.23M | $14.26M | $10.67M | $9.19M | $9.09M | $4.65M | $8.08M | $10.91M | $5.44M |
Low Forecast | $28.08M | $26.85M | $26.38M | $23.68M | $26.37M | $24.41M | $23.95M | $22.25M | $22.20M | $21.27M | $19.79M | $8.09M | $18.67M | $17.65M | $16.46M | $7.36M | $15.53M | $10.44M | $14.78M | $6.69M | $9.88M | $9.49M | $9.51M | $7.12M | $6.13M | $6.06M | $3.10M | $5.39M | $10.56M | $3.63M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 0.86% | 0.89% | 1.38% | 0.94% | 0.88% | - | 1.01% | 1.06% | 0.98% | 0.98% | 1.00% | 1.10% | 1.20% | 1.78% | 1.29% | 0.93% | 1.07% |
Addus HomeCare SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 3 | 4 | 5 | 6 | 4 | 6 | 4 | 6 | 4 | 5 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $60.77M | $60.27M | $57.40M | $56.36M | $54.47M | $54.23M | - | $53.15M | $49.54M | $46.28M | $48.17M | $45.43M | $44.21M | $40.73M | $42.45M | $45.17M | $41.69M | $38.71M |
Avg Forecast | $85.37M | $85.62M | $84.80M | $82.14M | $76.65M | $76.37M | $74.22M | $72.41M | $65.03M | $63.36M | $62.32M | $63.47M | $60.04M | $58.44M | $56.07M | $57.70M | $53.85M | $52.15M | $52.17M | $52.45M | $46.84M | $47.41M | $49.38M | $45.43M | $40.08M | $33.84M | $23.82M | $35.14M | $40.01M | $36.04M |
High Forecast | $85.92M | $86.16M | $85.34M | $82.66M | $77.13M | $76.85M | $74.69M | $72.87M | $65.45M | $63.82M | $62.72M | $76.16M | $60.54M | $58.81M | $56.43M | $69.24M | $54.19M | $62.58M | $52.17M | $62.94M | $56.21M | $56.89M | $59.26M | $54.51M | $48.10M | $40.61M | $28.59M | $42.16M | $40.49M | $43.24M |
Low Forecast | $84.59M | $84.83M | $84.02M | $81.39M | $75.94M | $75.66M | $73.54M | $71.75M | $64.44M | $62.85M | $61.75M | $50.77M | $59.49M | $57.90M | $55.56M | $46.16M | $53.35M | $41.72M | $52.17M | $41.96M | $37.48M | $37.93M | $39.50M | $36.34M | $32.07M | $27.07M | $19.06M | $28.11M | $39.49M | $28.83M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.03% | 1.02% | 0.98% | 1.01% | 1.04% | - | 1.01% | 1.06% | 0.98% | 0.98% | 1.00% | 1.10% | 1.20% | 1.78% | 1.29% | 1.04% | 1.07% |
Addus HomeCare EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 2 | 3 | 4 | 5 | 6 | 4 | 6 | 4 | 6 | 4 | 5 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $1.20 | $0.96 | $0.92 | $0.79 | $0.92 | $0.72 | - | $0.54 | $0.82 | $0.73 | $0.73 | $0.56 | $0.53 | $0.58 | $0.44 | $0.56 | $0.64 | $0.31 |
Avg Forecast | $1.72 | $1.65 | $1.62 | $1.45 | $1.62 | $1.50 | $1.47 | $1.36 | $1.36 | $1.30 | $1.21 | $1.11 | $1.17 | $1.08 | $1.01 | $0.88 | $0.95 | $0.92 | $0.90 | $0.75 | $0.91 | $0.89 | $0.87 | $0.74 | $0.73 | $0.64 | $0.48 | $0.60 | $0.66 | $0.57 |
High Forecast | $1.74 | $1.66 | $1.63 | $1.46 | $1.63 | $1.51 | $1.48 | $1.38 | $1.37 | $1.34 | $1.22 | $1.12 | $1.19 | $1.09 | $1.02 | $0.88 | $0.96 | $0.93 | $0.90 | $0.76 | $0.92 | $0.90 | $0.88 | $0.75 | $0.75 | $0.65 | $0.49 | $0.61 | $0.67 | $0.58 |
Low Forecast | $1.70 | $1.63 | $1.60 | $1.44 | $1.60 | $1.48 | $1.45 | $1.35 | $1.35 | $1.29 | $1.20 | $1.10 | $1.13 | $1.07 | $1.00 | $0.86 | $0.94 | $0.91 | $0.90 | $0.74 | $0.89 | $0.87 | $0.85 | $0.73 | $0.72 | $0.63 | $0.47 | $0.59 | $0.65 | $0.56 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.89% | 0.91% | 0.90% | 0.97% | 0.78% | - | 0.72% | 0.90% | 0.82% | 0.84% | 0.76% | 0.73% | 0.90% | 0.91% | 0.94% | 0.97% | 0.55% |
Addus HomeCare Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
SGRY | Surgery Partners | $31.00 | $47.50 | 53.23% | Buy |
AMED | Amedisys | $96.91 | $143.38 | 47.95% | Hold |
EHAB | Enhabit | $8.10 | $10.25 | 26.54% | Hold |
OPCH | Option Care Health | $31.99 | $38.00 | 18.79% | Buy |
SEM | Select Medical | $35.23 | $40.00 | 13.54% | Buy |
INNV | InnovAge | $5.99 | $6.80 | 13.52% | Hold |
ACHC | Acadia Healthcare Company | $78.23 | $84.89 | 8.51% | Buy |
EHC | Encompass Health | $93.25 | $93.17 | -0.09% | Buy |
ADUS | Addus HomeCare | $130.13 | $123.00 | -5.48% | Buy |
UHS | Universal Health Services | $232.56 | $208.47 | -10.36% | Hold |
PNTG | Pennant Group | $34.52 | $30.67 | -11.15% | Buy |
ENSG | Ensign Group | $152.73 | $114.25 | -25.19% | Buy |
ADUS Forecast FAQ
Is Addus HomeCare a good buy?
Yes, according to 6 Wall Street analysts, Addus HomeCare (ADUS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 83.33% of ADUS's total ratings.
What is ADUS's price target?
Addus HomeCare (ADUS) average price target is $123 with a range of $83 to $141, implying a -5.48% from its last price of $130.13. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Addus HomeCare stock go up soon?
According to Wall Street analysts' prediction for ADUS stock, the company can go down by -5.48% (from the last price of $130.13 to the average price target of $123), up by 8.35% based on the highest stock price target, and down by -36.22% based on the lowest stock price target.
Can Addus HomeCare stock reach $200?
ADUS's average twelve months analyst stock price target of $123 does not support the claim that Addus HomeCare can reach $200 in the near future.
What are Addus HomeCare's analysts' financial forecasts?
Addus HomeCare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.37B (high $1.38B, low $1.36B), average EBITDA is $118.1M (high $118.85M, low $117.02M), average net income is $98.15M (high $98.96M, low $96.97M), average SG&A $299.64M (high $301.55M, low $296.89M), and average EPS is $5.95 (high $6, low $5.88). ADUS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.54B (high $1.55B, low $1.53B), average EBITDA is $133.19M (high $134.04M, low $131.97M), average net income is $106.26M (high $107.14M, low $104.99M), average SG&A $337.93M (high $340.08M, low $334.83M), and average EPS is $6.44 (high $6.49, low $6.36).
Did the ADUS's actual financial results beat the analysts' financial forecasts?
Based on Addus HomeCare's last annual report (Dec 2023), the company's revenue was $1.06B, beating the average analysts forecast of $1.05B by 1.02%. Apple's EBITDA was $106.56M, beating the average prediction of $87.35M by 21.99%. The company's net income was $62.52M, missing the average estimation of $63.06M by -0.86%. Apple's SG&A was $234.79M, beating the average forecast of $232.25M by 1.10%. Lastly, the company's EPS was $3.83, missing the average prediction of $4.14 by -7.49%. In terms of the last quarterly report (Dec 2023), Addus HomeCare's revenue was $276.35M, beating the average analysts' forecast of $274.47M by 0.69%. The company's EBITDA was $33.02M, beating the average prediction of $23.66M by 39.52%. Addus HomeCare's net income was $19.58M, beating the average estimation of $19.34M by 1.23%. The company's SG&A was $60.77M, beating the average forecast of $60.04M by 1.21%. Lastly, the company's EPS was $1.2, beating the average prediction of $1.17 by 2.36%